Briefing Note: Phase II Engagement - National Strategy for Drugs for Rare Diseases

Title:
Phase II Engagement - National Strategy for Drugs for Rare Diseases
Additional Information:
-
Received:
Feb 28, 2022
Organization:
Health Canada
Sector:
SPB: Strategic Policy Branch
Addressee:
Minister
Action Required:
For Information
Reference Number:
22-102527-380